| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |